Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome].
López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Bryce A, Parra-Carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Bendersky M, Schmid H, Botero R, Urina M, Lara J, Foss MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A; Grupo de Especialistas da América Latina. López-Jaramillo P, et al. Among authors: harrap s. Arq Bras Endocrinol Metabol. 2014 Apr;58(3):205-25. doi: 10.1590/0004-2730000003019. Arq Bras Endocrinol Metabol. 2014. PMID: 24863082 Portuguese.
Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome.
López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Bryce A, Parra Carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Bendersky M, Schmid H, Botero R, Urina M, Lara J, Foss MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A; Latin America Expert Group. López-Jaramillo P, et al. Among authors: harrap s. J Hypertens. 2013 Feb;31(2):223-38. doi: 10.1097/HJH.0b013e32835c5444. J Hypertens. 2013. PMID: 23282894
[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome].
López-Jaramillo P, Sánchez RA, Díaz M, Cobos L, Bryce A, Parra-Carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Benderky M, Schmid H, Botero R, Urina M, Lara J, Foos MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A; nombre del Grupo de Expertos de Latinoamérica. López-Jaramillo P, et al. Among authors: harrap s. Clin Investig Arterioscler. 2014 Mar-Apr;26(2):85-103. doi: 10.1016/j.arteri.2013.11.008. Epub 2013 Dec 22. Clin Investig Arterioscler. 2014. PMID: 24365579 Spanish.
The World Hypertension League and International Society of Hypertension call on governments, nongovernmental organizations, and the food industry to work to reduce dietary sodium.
Campbell N, Lackland D, Chockalingam A, Lisheng L, Schiffrin EL, Harrap S, Touyz RM, Burrell L, Ramírez A, Schmieder R, Aletta S, Prabhakaran D. Campbell N, et al. Among authors: harrap s. J Clin Hypertens (Greenwich). 2014 Feb;16(2):99-100. doi: 10.1111/jch.12245. Epub 2014 Jan 15. J Clin Hypertens (Greenwich). 2014. PMID: 24422889 Free PMC article. No abstract available.
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group. Ninomiya T, et al. Among authors: harrap s. J Hypertens. 2010 Jun;28(6):1141-9. J Hypertens. 2010. PMID: 20486273 Clinical Trial.
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Chalmers J, Arima H, Woodward M, Mancia G, Poulter N, Hirakawa Y, Zoungas S, Patel A, Williams B, Harrap S. Chalmers J, et al. Among authors: harrap s. Hypertension. 2014 Feb;63(2):259-64. doi: 10.1161/HYPERTENSIONAHA.113.02252. Epub 2013 Dec 9. Hypertension. 2014. PMID: 24324048 Clinical Trial.
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.
Atkins ER, Hirakawa Y, Salam A, Woodward M, Cooper M, Hamet P, Harrap S, Lees K, Liu L, Mancia G, Marre M, Perkovic V, Poulter N, Williams B, Chalmers J, Rodgers A. Atkins ER, et al. Among authors: harrap s. J Hypertens. 2017 Jun;35(6):1318-1325. doi: 10.1097/HJH.0000000000001287. J Hypertens. 2017. PMID: 28169881
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.
Ohkuma T, Woodward M, Jun M, Muntner P, Hata J, Colagiuri S, Harrap S, Mancia G, Poulter N, Williams B, Rothwell P, Chalmers J; ADVANCE Collaborative Group. Ohkuma T, et al. Among authors: harrap s. Hypertension. 2017 Aug;70(2):461-468. doi: 10.1161/HYPERTENSIONAHA.117.09359. Epub 2017 Jun 5. Hypertension. 2017. PMID: 28584014 Clinical Trial.
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
Rahman F, McEvoy JW, Ohkuma T, Marre M, Hamet P, Harrap S, Mancia G, Rodgers A, Selvin E, Williams B, Muntner P, Chalmers J, Woodward M. Rahman F, et al. Among authors: harrap s. Hypertension. 2019 Jun;73(6):1291-1299. doi: 10.1161/HYPERTENSIONAHA.118.12414. Hypertension. 2019. PMID: 31030606 Free PMC article. Clinical Trial.
246 results